291 related articles for article (PubMed ID: 29808414)
1. 2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary.
Losa F; Iglesias L; Pané M; Sanz J; Nieto B; Fusté V; de la Cruz-Merino L; Concha Á; Balañá C; Matías-Guiu X
Clin Transl Oncol; 2018 Nov; 20(11):1361-1372. PubMed ID: 29808414
[TBL] [Abstract][Full Text] [Related]
2. [2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary].
Matías-Guiu X; Fusté V; Iglesias L; Balañá C; Concha Á; de la Cruz-Merino L; Nieto B; Pané M; Sanz J; Losa F
Rev Esp Patol; 2019; 52(1):33-44. PubMed ID: 30583830
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
García-Alfonso P; Salazar R; García-Foncillas J; Musulén E; García-Carbonero R; Payá A; Pérez-Segura P; Ramón y Cajal S; Navarro S; ;
Clin Transl Oncol; 2012 Oct; 14(10):726-39. PubMed ID: 22855150
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Remon J; García-Campelo R; de Álava E; Vera R; Rodríguez-Peralto JL; Rodríguez-Lescure Á; Bellosillo B; Garrido P; Rojo F; Álvarez-Alegret R
Clin Transl Oncol; 2020 Jun; 22(6):823-834. PubMed ID: 31559582
[TBL] [Abstract][Full Text] [Related]
5. Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Alfonso P; García-Foncillas J; Salazar R; Pérez-Segura P; García-Carbonero R; Musulén-Palet E; Cuatrecasas M; Landolfi S; Ramón Y Cajal S; Navarro S; ;
Clin Transl Oncol; 2015 Apr; 17(4):264-73. PubMed ID: 25373533
[TBL] [Abstract][Full Text] [Related]
6. [Cancer of unknown primary site origin--advances in diagnosis and therapy].
Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H
Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808
[TBL] [Abstract][Full Text] [Related]
7. NCCN Clinical Practice Guidelines Occult primary.
Ettinger DS; Agulnik M; Cates JM; Cristea M; Denlinger CS; Eaton KD; Fidias PM; Gierada D; Gockerman JP; Handorf CR; Iyer R; Lenzi R; Phay J; Rashid A; Saltz L; Shulman LN; Smerage JB; Varadhachary GR; Zager JS; Zhen WK;
J Natl Compr Canc Netw; 2011 Dec; 9(12):1358-95. PubMed ID: 22157556
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology.
de Castro J; Cobo M; Isla D; Puente J; Reguart N; Cabeza B; Gayete A; Sánchez M; Torres MI; Ferreirós J
Clin Transl Oncol; 2015 Jan; 17(1):11-23. PubMed ID: 25373531
[TBL] [Abstract][Full Text] [Related]
9. Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).
Sbardella E; Isidori AM; Arnaldi G; Arosio M; Barone C; Benso A; Berardi R; Capasso G; Caprio M; Ceccato F; Corona G; Della Casa S; De Nicola L; Faustini-Fustini M; Fiaccadori E; Gesualdo L; Gori S; Lania A; Mantovani G; Menè P; Parenti G; Pinto C; Pivonello R; Razzore P; Regolisti G; Scaroni C; Trepiccione F; Lenzi A; Peri A;
J Endocrinol Invest; 2018 Jan; 41(1):3-19. PubMed ID: 29152673
[No Abstract] [Full Text] [Related]
10. [Peritoneal carcinomatosis of unknown origin].
Marchal N; Gennigens C; Jerusalem G
Rev Med Liege; 2012 Nov; 67(11):582-6. PubMed ID: 23346828
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
12. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
[TBL] [Abstract][Full Text] [Related]
13. A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.
Pauli C; Bochtler T; Mileshkin L; Baciarello G; Losa F; Ross JS; Pentheroudakis G; Zarkavelis G; Yalcin S; Özgüroğlu M; Beringer A; Scarato J; Mueller-Ohldach M; Thomas M; Moch H; Krämer A
Oncologist; 2021 May; 26(5):e769-e779. PubMed ID: 33687747
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of unknown primary (CUP): an update for histopathologists.
Beauchamp K; Moran B; O'Brien T; Brennan D; Crown J; Sheahan K; Cotter MB
Cancer Metastasis Rev; 2023 Dec; 42(4):1189-1200. PubMed ID: 37394540
[TBL] [Abstract][Full Text] [Related]
15. Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients.
Otero MJ; Vera R; González-Pérez C; Ayala de la Peña F; Peñuelas Á; Quer N
Farm Hosp; 2018 Nov; 42(6):261-268. PubMed ID: 30381047
[TBL] [Abstract][Full Text] [Related]
16. [Metastases of unknown origin--principles of diagnosis and treatment].
Petrović D; Muzikravić L; Jovanović D
Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
[TBL] [Abstract][Full Text] [Related]
17. [Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Álvarez-Alegret R; Rojo Todo F; Garrido P; Bellosillo B; Rodríguez-Lescure Á; Rodríguez-Peralto JL; Vera R; de Álava E; García-Campelo R; Remon J
Rev Esp Patol; 2020; 53(4):234-245. PubMed ID: 33012494
[TBL] [Abstract][Full Text] [Related]
18. Cancers of unknown primary origin: current perspectives and future therapeutic strategies.
Stella GM; Senetta R; Cassenti A; Ronco M; Cassoni P
J Transl Med; 2012 Jan; 10():12. PubMed ID: 22272606
[TBL] [Abstract][Full Text] [Related]
19. Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?
Olivier T; Fernandez E; Labidi-Galy I; Dietrich PY; Rodriguez-Bravo V; Baciarello G; Fizazi K; Patrikidou A
Cancer Treat Rev; 2021 Jun; 97():102204. PubMed ID: 33866225
[TBL] [Abstract][Full Text] [Related]
20. Predictors of care for patients with cancer of unknown primary site in three Australian hospitals.
Tan SYS; O'Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e512-e520. PubMed ID: 29105289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
